Agarwal Arjun
Reporting owner on Forms 3, 4 and 5, CIK 2033974.
Agarwal Arjun reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-13.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ORKA · Oruka Therapeutics, Inc.CIK 907654 | officer (Senior Vice President, Finance) | 2 | 2026-11-13 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-12 | M exercised | +8,542 | $12.5 | 22,761 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-12 | M exercised | +1,458 | $34.39 | 24,219 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-12 | S sold | -500 | $101.9758 | 23,719 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-12 | S sold | -801 | $103.1556 | 22,918 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-12 | S sold | -799 | $104.2502 | 22,119 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-12 | S sold | -6,842 | $105.2806 | 15,277 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-12 | S sold | -958 | $106.1759 | 14,319 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-12 | S sold | -100 | $107 | 14,219 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Employee Stock Option (right to buy), derivative | 2026-11-12 | M exercised | -8,542 | $0 | 67,834 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Employee Stock Option (right to buy), derivative | 2026-11-12 | M exercised | -1,458 | $0 | 55,417 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-12 | M exercised | +8,541 | $12.5 | 22,760 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-12 | M exercised | +1,458 | $34.39 | 24,218 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-12 | S sold | -5,741 | $80.0302 | 18,477 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-12 | S sold | -2,100 | $80.7601 | 16,377 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-12 | S sold | -1,958 | $81.8551 | 14,419 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-12 | S sold | -200 | $82.835 | 14,219 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Employee Stock Option (right to buy), derivative | 2026-10-12 | M exercised | -8,541 | $0 | 76,376 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Employee Stock Option (right to buy), derivative | 2026-10-12 | M exercised | -1,458 | $0 | 56,875 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0000907654-26-000116 | Oruka Therapeutics, Inc. | 2026-11-13 | ||
| Form 4 0000907654-26-000106 | Oruka Therapeutics, Inc. | 2026-10-13 |